{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalGuideline"
  ],
  "@id": "health-sciences:medicine:cardiology:cardio-003",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:50:10.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "cardiology-knowledge-base"
    ],
    "confidence": 0.96,
    "status": "validated",
    "modified": "2026-01-11T14:24:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/cardiology",
    "type": "management",
    "difficulty": "intermediate",
    "importance": "critical",
    "aku_id": "003",
    "keywords": [
      "NSTEMI",
      "non-ST elevation myocardial infarction",
      "unstable angina",
      "acute coronary syndrome",
      "risk stratification",
      "invasive strategy"
    ],
    "medical_specialty": "cardiology",
    "clinical_context": "acute_coronary_syndrome"
  },
  "content": {
    "title": "NSTEMI Management",
    "summary": "Risk stratification and evidence-based management of non-ST elevation myocardial infarction",
    "key_points": [
      "NSTEMI = elevated troponin + ischemic symptoms/ECG changes without ST elevation",
      "Risk stratify using TIMI, GRACE, or HEART scores",
      "High-risk features warrant early invasive strategy (<24 hours)",
      "Dual antiplatelet therapy + anticoagulation for all",
      "Timing of angiography based on risk category",
      "Complete revascularization improves outcomes"
    ],
    "statement": {
      "text": "Non-ST elevation myocardial infarction (NSTEMI) management involves immediate antithrombotic therapy (aspirin, P2Y12 inhibitor, anticoagulation), risk stratification to determine invasive strategy timing, and revascularization when appropriate. Very high-risk patients require immediate angiography (<2 hours); high-risk patients need early invasive strategy (<24 hours); intermediate-risk can have delayed invasive or ischemia-guided approach.",
      "formal": "NSTEMI Management = Antithrombotic therapy + Risk stratification \u2192 [Very high risk: <2h angio | High risk: <24h angio | Intermediate: <72h or ischemia-guided]"
    },
    "explanation": {
      "intuition": "NSTEMI typically involves subtotal or intermittent coronary occlusion - the artery is partially blocked, unlike STEMI where it's completely blocked. This means there's more time for decision-making, but the patient is still at significant risk. Risk stratification helps determine who benefits most from early intervention.",
      "key_insight": "The key difference from STEMI is timing: NSTEMI allows hours to days for catheterization decisions based on risk. However, very high-risk features (ongoing ischemia, hemodynamic instability, arrhythmias) mandate immediate intervention just like STEMI.",
      "technical_details": "GRACE score best predicts mortality and is recommended for risk stratification. TIMI score is simpler but less accurate. Invasive strategy means coronary angiography with intent to revascularize; ischemia-guided means medical management with angiography only if recurrent ischemia or positive stress test."
    },
    "definitions_glossary": {
      "NSTEMI": "Myocardial infarction with elevated troponin but without ST-segment elevation on ECG",
      "unstable_angina": "ACS with ischemic symptoms but without troponin elevation - now rare with high-sensitivity troponin",
      "TIMI_risk_score": "7-point score predicting 14-day mortality/ischemic events in NSTE-ACS",
      "GRACE_score": "Registry-based score predicting in-hospital and 6-month mortality in ACS",
      "HEART_score": "5-category score for chest pain risk stratification in emergency department",
      "invasive_strategy": "Routine coronary angiography with intent to revascularize regardless of stress testing",
      "ischemia_guided_strategy": "Medical management with angiography only for recurrent ischemia or positive stress test",
      "dual_antiplatelet_therapy": "Aspirin plus P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel)",
      "complete_revascularization": "Treatment of all significant coronary stenoses, not just culprit lesion",
      "culprit_lesion": "The specific coronary stenosis responsible for the acute event",
      "refractory_ischemia": "Persistent or recurrent chest pain despite optimal medical therapy",
      "dynamic_ECG_changes": "New or changing ST-T abnormalities during chest pain episodes"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Partial or intermittent coronary occlusion, often due to plaque rupture with non-occlusive thrombus. Unlike STEMI, some antegrade flow is preserved, preventing transmural ischemia. However, the unstable plaque can progress to complete occlusion at any time.",
      "spectrum": "NSTE-ACS represents a spectrum from unstable angina (no biomarker elevation) to NSTEMI (troponin positive). With high-sensitivity troponin, most patients previously classified as unstable angina are now reclassified as NSTEMI."
    },
    "diagnostic_criteria": {
      "definition": "Rise and/or fall of cardiac troponin with at least one value above 99th percentile, PLUS clinical features of myocardial ischemia, WITHOUT persistent ST-segment elevation",
      "ECG_findings": [
        "ST depression (\u22650.5mm horizontal or downsloping)",
        "Transient ST elevation (<20 minutes)",
        "T-wave inversions (especially deep, symmetric)",
        "New T-wave flattening or pseudo-normalization",
        "May have normal ECG (does not exclude NSTEMI)"
      ]
    },
    "risk_stratification": {
      "very_high_risk_features": [
        "Hemodynamic instability or cardiogenic shock",
        "Recurrent or ongoing chest pain refractory to medical therapy",
        "Life-threatening arrhythmias (VT, VF, complete heart block)",
        "Mechanical complications (acute MR, VSD)",
        "Acute heart failure clearly related to NSTE-ACS"
      ],
      "high_risk_features": [
        "Rise and/or fall of troponin",
        "Dynamic ST or T-wave changes",
        "GRACE score >140",
        "TIMI score \u22655",
        "Diabetes mellitus",
        "Renal insufficiency (eGFR <60)",
        "LVEF <40%",
        "Early post-infarction angina",
        "Prior PCI within 6 months or prior CABG"
      ],
      "GRACE_score_components": {
        "variables": [
          "Age",
          "Heart rate",
          "Systolic BP",
          "Creatinine",
          "Killip class",
          "Cardiac arrest at admission",
          "ST deviation",
          "Elevated troponin"
        ],
        "interpretation": {
          "low": "<109 (in-hospital mortality <1%)",
          "intermediate": "109-140 (1-3%)",
          "high": ">140 (>3%)"
        }
      },
      "TIMI_risk_score": {
        "components": [
          "Age \u226565",
          "\u22653 CAD risk factors",
          "Known CAD (stenosis \u226550%)",
          "ASA use in past 7 days",
          "Severe angina (\u22652 episodes in 24h)",
          "ST changes \u22650.5mm",
          "Elevated cardiac markers"
        ],
        "scoring": "1 point each; 0-2 low, 3-4 intermediate, 5-7 high risk"
      }
    },
    "treatment_options": {
      "immediate_management": [
        "Aspirin 325mg (if not already on aspirin)",
        "P2Y12 inhibitor: ticagrelor 180mg preferred, or clopidogrel 600mg",
        "Anticoagulation: UFH, enoxaparin, or fondaparinux",
        "Nitroglycerin for ongoing ischemia",
        "Beta-blocker (oral, if no contraindications)",
        "High-intensity statin"
      ],
      "invasive_strategy_timing": {
        "immediate_less_than_2_hours": "Very high-risk features (hemodynamic instability, ongoing ischemia, arrhythmias)",
        "early_less_than_24_hours": "High-risk features (GRACE >140, troponin positive, dynamic ECG changes)",
        "delayed_24_to_72_hours": "Intermediate risk features",
        "selective_ischemia_guided": "Low-risk patients without recurrent symptoms or positive stress test"
      },
      "antiplatelet_agents": {
        "aspirin": "Indefinite, 81mg daily after loading dose",
        "ticagrelor": "180mg load, then 90mg BID \u00d7 12 months; preferred over clopidogrel",
        "clopidogrel": "600mg load, then 75mg daily \u00d7 12 months; if ticagrelor contraindicated",
        "prasugrel": "60mg load, then 10mg daily; use only after coronary anatomy known; avoid if prior stroke/TIA"
      },
      "anticoagulation_options": {
        "UFH": "Weight-based bolus + infusion; for PCI-bound patients",
        "enoxaparin": "1mg/kg SC q12h; if renal function adequate",
        "fondaparinux": "2.5mg SC daily; if conservative strategy planned (add UFH if PCI)"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "NSTEMI Management"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "Non-ST Elevation MI Management"
      },
      {
        "@language": "en",
        "@value": "NSTE-ACS Management"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Evidence-based approach to managing non-ST elevation myocardial infarction including antithrombotic therapy, risk stratification, and determination of invasive versus conservative strategy"
    },
    "notation": "cardio-003",
    "scopeNote": "Based on 2014 AHA/ACC NSTE-ACS Guidelines and 2021 ESC Guidelines",
    "example": "68-year-old diabetic female with troponin 0.85 ng/mL, ST depression V4-V6, GRACE score 152 - high-risk NSTEMI requiring early invasive strategy within 24 hours"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "401314000",
      "uri": "http://snomed.info/id/401314000",
      "description": "Acute non-ST segment elevation myocardial infarction (disorder)",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I21.4",
      "description": "Non-ST elevation (NSTEMI) myocardial infarction",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D000072658",
      "uri": "http://id.nlm.nih.gov/mesh/D000072658",
      "description": "Non-ST Elevated Myocardial Infarction",
      "matchType": "exactMatch"
    }
  ],
  "pedagogical": {
    "target_audience": [
      "internal_medicine_residents",
      "cardiology_fellows",
      "emergency_medicine_physicians",
      "hospitalists"
    ],
    "estimated_time": "40min",
    "difficulty_curve": 0.72,
    "learning_objectives": [
      "Apply GRACE and TIMI risk scores to NSTEMI patients",
      "Identify very high-risk features requiring immediate intervention",
      "Select appropriate antiplatelet and anticoagulation regimens",
      "Determine optimal timing of invasive strategy",
      "Understand invasive vs ischemia-guided approach evidence"
    ],
    "clinical_pearls": [
      "GRACE score predicts mortality better than TIMI for catheterization timing decisions",
      "Ticagrelor preferred over clopidogrel for better outcomes (PLATO trial)",
      "Prasugrel only after anatomy known - higher bleeding, contraindicated if prior stroke",
      "Very high-risk features (shock, ongoing ischemia, VT/VF) = immediate cath like STEMI",
      "Fondaparinux has less bleeding but needs UFH supplement at PCI time"
    ],
    "board_yield": {
      "usmle_step2": "Very High - risk stratification, treatment algorithm",
      "usmle_step3": "High - antiplatelet selection, timing of intervention",
      "internal_medicine_boards": "Very High - comprehensive management approach",
      "cardiology_boards": "Critical - nuanced decision-making"
    }
  },
  "relationships": {
    "prerequisites": [
      {
        "id": "health-sciences:medicine:cardiology:cardio-001",
        "title": "Myocardial Infarction Definition",
        "strength": 1.0
      },
      {
        "id": "health-sciences:medicine:cardiology:cardio-002",
        "title": "STEMI Criteria",
        "strength": 0.9
      }
    ],
    "skos:broader": [
      {
        "@id": "health-sciences:medicine:cardiology:cardio-047",
        "@type": "skos:Concept",
        "skos:prefLabel": "Acute Coronary Syndrome"
      }
    ],
    "skos:related": [
      {
        "@id": "health-sciences:medicine:cardiology:cardio-031",
        "@type": "skos:Concept",
        "skos:prefLabel": "PCI Procedure",
        "skos:note": "Revascularization option for NSTEMI"
      },
      {
        "@id": "health-sciences:medicine:cardiology:cardio-048",
        "@type": "skos:Concept",
        "skos:prefLabel": "Cardiac Biomarkers",
        "skos:note": "Troponin defines NSTEMI vs unstable angina"
      }
    ],
    "owl:sameAs": [
      "http://snomed.info/id/401314000",
      "http://www.wikidata.org/entity/Q2388879"
    ],
    "skos:exactMatch": [
      "http://snomed.info/id/401314000"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T14:24:00.000Z",
    "sources": [
      {
        "source": "Amsterdam EA, et al. 2014 AHA/ACC Guideline for NSTE-ACS. Circulation 2014;130:e344-e426",
        "type": "clinical_guideline",
        "year": 2014,
        "confidence": 1.0,
        "relevance": "Primary US guideline for NSTE-ACS management"
      },
      {
        "source": "Collet JP, et al. 2020 ESC Guidelines for NSTE-ACS. Eur Heart J 2021;42:1289-1367",
        "type": "clinical_guideline",
        "year": 2021,
        "confidence": 1.0,
        "relevance": "Updated European guideline"
      }
    ]
  },
  "quality_assessment": {
    "CQS": 0.94,
    "completeness": 0.95,
    "accuracy": 0.96,
    "clarity": 0.93,
    "pedagogical_quality": 0.94,
    "ontology_alignment": 0.94,
    "last_assessment": "2026-01-11T14:24:00.000Z",
    "assessor": "quality-enhancement-agent"
  },
  "rendering_hints": {
    "primary_representation": "management_algorithm",
    "show_images": true,
    "visualization": [
      "risk_stratification_flowchart",
      "GRACE_TIMI_score_calculators",
      "invasive_timing_algorithm"
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Non-ST_elevation_myocardial_infarction",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q2388879"
}